AeRangKimMDPhD

Pediatric Hematology & Oncology • Washington, DC

Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Associate Professor, Pediatrics, George Washington University School of Medicine and Health Sciences

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
111 Michigan Avenue Northwest
Washington, DC 20010
Phone+1 202-476-2800

Fax+1 202-476-5685

Education & Training

Johns Hopkins Bloomberg School of Public HealthPhD, 2005 - 2009
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2004 - 2008
NYU Grossman School of MedicineResidency, Pediatrics, 2001 - 2004
University of Illinois College of MedicineClass of 2001

Certifications & Licensure

MD State Medical License 2005 - 2026
VA State Medical License 2022 - 2026
DC State Medical License 2010 - 2024
NY State Medical License 2003 - 2005
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy Start of enrollment: 2001 Nov 01
Completed
Phase 1
Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer Start of enrollment: 2012 Jan 01
Completed
Phase 2
SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) Start of enrollment: 2013 Dec 01
Completed
Phase 1, Phase 2
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors Start of enrollment: 2014 Apr 01
Active, not recruiting
Phase 1
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Start of enrollment: 2016 Oct 01
Terminated
Phase 1
A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors Start of enrollment: 2015 Dec 11
Completed
Phase 1
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Start of enrollment: 2016 Mar 01
Completed
Phase 1, Phase 2
Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Start of enrollment: 2019 May 17
Completed
Phase 1
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor Start of enrollment: 2020 Jan 22
Active, not recruiting
Phase 1, Phase 2
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma Start of enrollment: 2020 Mar 04
Terminated
Phase 1, Phase 2
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors Start of enrollment: 2019 Jan 28
Recruiting
Roles: Contact
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors Start of enrollment: 2024 Jun 26
Not yet recruiting
Phase 1, Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

5 citations
Focused Ultrasound for Pediatric Diseases.
Rohan Janwadkar, Suzanne Leblang, Pejman Ghanouni, Jacqueline Brenner, John Ragheb
Pediatrics. 2022-03-01
215 citations
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis...
Markku Miettinen, Cristina R. Antonescu, Christopher D.M. Fletcher, AeRang Kim, Alexander J. Lazar
Human Pathology. 2017-09-01
33 citations
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, Jaishri O Blakeley, Gideon Bollag
Neuro-Oncology. 2022-11-02

Press Mentions

Children’s National Hospital Becomes First Pediatric Hospital Designated a Center of Excellence by Focused Ultrasound FoundationSeptember 24th, 2020
A Melanoma Drug Shows Promise for NF1 PlexiformsSeptember 30th, 2019
MedCityNews – Pediatric Device Innovators Forum Explores State of Focused UltrasoundJuly 15th, 2021